Specifically, the warning says the drugs, which are used to treat anemia in patients with kidney failure and on chemotherapy, increased death and accelerated tumor growth in patients with early stage breast cancer and cervical cancer. Earlier labeling warned of similar risks in other types of cancer. The label notes the problems occurred when docs treated patients with elevated levels of the drugs, according to Amgen's statement.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments